A Revolution in Treatment for Hepatitis C Infection: Mitigating the Budgetary Impact.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 27243461.
- Also identified by DOI 10.1371/journal.pmed.1002031 and PMC identifier 4886960.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
In a Perspective accompanying Hill and colleagues, Elliot Marseille and James Kahn compare the history of pricing and availability of ART for HIV with that of the new HCV drugs and discuss strategies for providing treatment in LMIC even in the face of high costs.
Medical subject headings
- Antiviral Agents
- Hepatitis C